History & Tech Overview
How We Got Here
Tissue & Cell’s business was founded in 2011 with a pioneering vision to develop a platform for long-term cryo-storage of large volumes of human tissue and cells.
Our technology, which maintains cell vigor, viability, structure, and full functionality, is at the forefront of advancements in reconstructive surgery and regenerative medicine.

Fat banking has been referred to as a “Holy Grail” and one of the ten most important advances in plastic surgery in the last 20 years.
Tissue & Cell business are experts in cryopreservation of adipose tissue. And we are the only establishment with an approved cryopreservation process.
The U.K. Human Tissue Authority (HTA) issued a tissue establishment license to T&CT in 2005, which covers the safety of the transport kit, processing, and storage, also providing an assurance of integrity and quality.*
Our technology platform, Adiposet©, launched in the UK in 2014, is the result of more than 15 years of research in collaboration with the University of Sheffield. T&CT collaborates with over 25 NHS hospitals, and the list is growing.
Learn more about our Quality Management System here